Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:
Sign Up
| Overall Assessment |
Comment |
Score |
| Limited |
Kissei Pharmaceutical offers a limited but concrete view of its climate-policy engagement. It identifies one specific policy, the “長野県地球温暖化対策条例” and its linked Business Activity Global Warming Countermeasure Planning System, as the focus of its efforts. The company explains that it “collaborates directly with policy officials in Nagano Prefecture by creating three-year greenhouse-gas reduction plans and reporting annual progress,” which reveals a clear direct mechanism and a named governmental target. Beyond this description, no additional lobbying channels—such as written submissions, association work, or public consultations—are described. The company indicates that it fully supports the ordinance and aligns with the prefecture’s Zero Carbon Strategy to reduce emissions in line with the Paris Agreement, but it does not spell out any specific policy changes, amendments, or other concrete outcomes it is seeking. Consequently, while the disclosure provides some transparency around a single local engagement, it remains narrow in scope and detail.
|
1
|
| Overall Assessment |
Comment |
Score |
| Moderate |
Kissei Pharmaceutical has established limited processes to align its indirect external engagement on climate issues with its climate commitments, primarily through industry association participation, but it does not disclose a formal policy or dedicated oversight for its lobbying activities. The company reports that "当社は日本製薬工業協会（製薬協）の環境問題検討会（2022年4月発足）にメンバーとして参加しており、気候変動問題に対する課題検討や日本製薬団体連合会（日薬連）環境委員会への環境問題に関する製薬協の意見のとりまとめ等を行う", and that "検討会での内容については当社内のサステナビリティ推進委員会（旧SDGs推進委員会）においても情報共有し、社内での行動推進に繋げていく", demonstrating an internal committee reviewing and promoting actions based on association discussions. The company also notes its continued cooperation on the "日薬連カーボンニュートラル行動計画" through surveys, showing engagement at the indirect lobbying level. However, the company does not disclose any process for direct lobbying alignment, no named individual or formal governance body responsible for approving or reviewing lobbying positions, and states "No, and we do not plan to have one in the next two years" regarding a public commitment to align engagement with the Paris Agreement, indicating an absence of a comprehensive climate-lobbying governance framework.
|
2
|